Progress in GEO-CM04S1 BARDA/Project NextGen Phase 2b trial; multiple data readouts of existing COVID-19 vaccine Phase 2 ...

The reelection of former President Donald Trump, coupled with Republicans gaining the Senate majority and poised to gain the House majority, ...

Yes, you can get your flu and COVID-19 shots at the same time. Don't call them boosters — they're not just another dose of ...

H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Novavax (NVAX – Research Report) today and set a price target of ...

Across California, public health and pest control authorities are facing a new reality as the Aedes mosquitoes bring the ...

Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza combination (CIC ... confirming that the event was not related to the investigational ...

Sanofi will take the lead co-commercialization role for our COVID ... FDA and Novavax aligned on a single Phase 3 trial for both candidates with an updated trial design as shown in the graphic on the ...

Novavax’s COVID-19 vaccine won FDA approval in October 2023 ... of the quarter include the company’s emergency-use ...

There is no evidence Japan has named the COVID-19 vaccine the “most deadly drug in history,” as the post claims.

When Elanco decided to stop offering the incentives, causing a $160 million revenue decline, it cited the uncertainty of the ...

The latest update is out from Novavax ( (NVAX)). Novavax, a leader in vaccine development, announced the FDA’s removal of a clinical hold on their COVID-19-Influenza combination and influenza vaccine ...

Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.